Innovative approaches to managing pediatric hematologic malignancies: clinical and translational perspectives

Authors

  • Emmanuel Ifeanyi Obeagu Author

Keywords:

Pediatric hematology, Hematologic malignancies, Precision medicine, Gene therapy, Translational research

Abstract

Pediatric hematologic malignancies, encompassing acute leukemias, lymphomas, and rare myelodysplastic syndromes, remain a leading cause of childhood morbidity and mortality worldwide. Over the past decade, rapid advancements in molecular biology, immunotherapy, and gene-editing technologies have revolutionized diagnostic, prognostic, and therapeutic strategies. This narrative review explores innovative clinical and translational approaches in pediatric hematologic malignancies, highlighting precision medicine, novel pharmacologic interventions, immunotherapeutic modalities, and integrative strategies that bridge laboratory discoveries to bedside care. Emphasis is placed on recent breakthroughs in chimeric antigen receptor (CAR) T-cell therapy, targeted small-molecule inhibitors, and gene therapy, as well as challenges in implementation, including accessibility, safety, and long-term outcomes. By synthesizing current evidence, this review provides a framework for clinicians and researchers seeking to optimize patient-centered care and accelerate translational progress in pediatric hematology.

Downloads

Published

2025-11-04

How to Cite

[1]
Emmanuel Ifeanyi Obeagu 2025. Innovative approaches to managing pediatric hematologic malignancies: clinical and translational perspectives. The African Journal of Perinatology. 2, 2 (Nov. 2025), 95–105.

Similar Articles

You may also start an advanced similarity search for this article.